United Capital Financial Advisors LLC Takes $2.37 Million Position in Cencora, Inc. $COR

Key Points

• United Capital Financial Advisors initiated a $2.37 million position in Cencora during the second quarter, while institutional investors collectively own 97.52% of the company.
• Cencora reported quarterly earnings of $4.48 per share, beating expectations, on revenue of $84.75 billion—up 5.1% year over year. The board also authorized a $2 billion share-repurchase program.
• Analysts maintain a broadly positive outlook, with a consensus “Moderate Buy” rating and an average price target of $370.85 versus the stock’s reported price of $322.12.

United Capital Financial Advisors LLC bought a new stake in shares of Cencora, Inc. (NYSE:COR - Free Report) in the second quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor bought 8,387 shares of the company's stock, valued at approximately $2,373,000.

Several other large investors have also added to or reduced their stakes in the stock. United Bank increased its position in shares of Cencora by 4.5% during the second quarter. United Bank now owns 7,032 shares of the company's stock valued at $2,109,000 after buying an additional 305 shares during the period. Nebula Research & Development LLC purchased a new position in shares of Cencora during the 2nd quarter worth approximately $595,000. Treasurer of the State of North Carolina raised its position in shares of Cencora by 7.9% in the 2nd quarter. Treasurer of the State of North Carolina now owns 85,534 shares of the company's stock worth $25,647,000 after acquiring an additional 6,244 shares in the last quarter. Diversify Advisory Services LLC lifted its stake in shares of Cencora by 94.1% in the 2nd quarter. Diversify Advisory Services LLC now owns 2,585 shares of the company's stock valued at $747,000 after purchasing an additional 1,253 shares during the period. Finally, DZ BANK AG Deutsche Zentral Genossenschafts Bank Frankfurt am Main boosted its position in shares of Cencora by 26.0% during the second quarter. DZ BANK AG Deutsche Zentral Genossenschafts Bank Frankfurt am Main now owns 73,452 shares of the company's stock valued at $22,025,000 after purchasing an additional 15,154 shares in the last quarter. Institutional investors own 97.52% of the company's stock.

Insider Transactions at Cencora

In other news, EVP Elizabeth S. Campbell sold 11,300 shares of the company's stock in a transaction dated Monday, August 24th. The shares were sold at an average price of $324.12, for a total transaction of $3,662,556.00. Following the completion of the sale, the executive vice president owned 19,455 shares of the company's stock, valued at $6,305,754.60. This represents a 36.74% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, Director Lauren M. Tyler acquired 550 shares of the stock in a transaction dated Monday, June 22nd. The stock was acquired at an average price of $270.23 per share, for a total transaction of $148,626.50. Following the purchase, the director directly owned 4,359 shares in the company, valued at approximately $1,177,932.57. This trade represents a 14.44% increase in their ownership of the stock. Additional details regarding this purchase are available in the official SEC disclosure. Insiders own 0.38% of the company's stock.

Analysts Set New Price Targets

A number of research firms have recently weighed in on COR. Citigroup reaffirmed a "buy" rating on shares of Cencora in a research report on Thursday, August 6th. Bank of America raised their target price on shares of Cencora from $280.00 to $285.00 and gave the company a "neutral" rating in a research note on Wednesday, June 24th. JPMorgan Chase & Co. boosted their price target on Cencora from $382.00 to $390.00 and gave the stock an "overweight" rating in a research report on Friday, August 7th. Morgan Stanley raised their price objective on Cencora from $342.00 to $346.00 and gave the company an "overweight" rating in a research report on Friday, August 7th. Finally, Royal Bank Of Canada started coverage on Cencora in a research note on Wednesday, August 19th. They set a "sector perform" rating and a $330.00 price objective for the company. Thirteen analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the stock. According to data from MarketBeat.com, Cencora presently has a consensus rating of "Moderate Buy" and an average target price of $370.85.

Cencora Trading Up 0.3%

NYSE:COR opened at $322.12 on Friday. The company has a market cap of $61.47 billion, a PE ratio of 23.93, a price-to-earnings-growth ratio of 1.84 and a beta of 0.57. The company has a current ratio of 0.93, a quick ratio of 0.58 and a debt-to-equity ratio of 3.53. The company has a 50 day simple moving average of $307.38 and a two-hundred day simple moving average of $310.88. Cencora, Inc. has a 12 month low of $244.82 and a 12 month high of $377.54.

Cencora (NYSE:COR - Get Free Report) last released its quarterly earnings results on Wednesday, August 5th. The company reported $4.48 earnings per share for the quarter, beating the consensus estimate of $4.35 by $0.13. Cencora had a return on equity of 125.45% and a net margin of 0.79%.The firm had revenue of $84.75 billion for the quarter, compared to analysts' expectations of $84.31 billion. During the same period in the prior year, the firm earned $4.00 EPS. The company's revenue was up 5.1% compared to the same quarter last year. Research analysts forecast that Cencora, Inc. will post 17.87 earnings per share for the current year.

Cencora announced that its board has approved a stock repurchase program on Thursday, May 21st that authorizes the company to repurchase $2.00 billion in shares. This repurchase authorization authorizes the company to repurchase up to 3.9% of its stock through open market purchases. Stock repurchase programs are often a sign that the company's board of directors believes its stock is undervalued.

Cencora Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Monday, August 31st. Shareholders of record on Friday, August 14th will be given a $0.60 dividend. This represents a $2.40 annualized dividend and a yield of 0.7%. The ex-dividend date of this dividend is Friday, August 14th. Cencora's dividend payout ratio (DPR) is presently 17.83%.

Cencora Profile

Cencora NYSE: COR is a global healthcare services and pharmaceutical distribution company that provides end-to-end solutions across the pharmaceutical supply chain. The company's core activities include wholesale drug distribution, specialty drug distribution, and the operation of specialty pharmacies, complemented by logistics, cold-chain management and other fulfillment services designed to support complex and temperature-sensitive therapies.

Beyond physical distribution, Cencora offers a range of commercial and patient-focused services for pharmaceutical manufacturers and healthcare providers.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source